Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2007
11/08/2007US20070258972 Combination of a Histone Deacetylase Inhibitor with a Death Receptor Ligand
11/08/2007US20070258968 modified deoxycytidine kinase (dCK) mutants with enhanced activity towards nucleoside analogs used in cancer chemotherapy, and delivering the enzymes to specific target cells; specifically delivered to leukemic blast cells
11/08/2007US20070258964 Preparing selenium-enriched biomass having Se-methionine content of at least 11.39 ng/mgd.w. by culturing microorganisms selected from Lactobacillus reuteri DSM16143, Lactobacillus ferintoshensis DSM16144 and Lactobacillus buchneri/parabuchneri DSM16341 in culture medium comprising selenium salt
11/08/2007US20070258963 Mesenchymal stem cells expressing TNF-alpha receptors
11/08/2007US20070258961 Cholesterol efflux and uses thereof
11/08/2007US20070258944 Multiple cytokine protein complexes
11/08/2007US20070258906 Methods and devices for detection and therapy of atheromatous plaque
11/08/2007US20070258903 Methods, compositions and devices for treating lesioned sites using bioabsorbable carriers
11/08/2007US20070258900 Blood Flow Assessment of Clostridial Toxin Applications
11/08/2007US20070258897 Antibodies Against Bacterial Antigens and Their Use in the Generation of Immune Responses Against Apoptotic Cells
11/08/2007DE10054303B4 Analoga, Agonisten, Antagonisten und Varianten der Oxidoreduktase-Enzymaktivität des Makrophagen-Migrations-Inhibitions-Faktors (MIF) als Immunmodulatoren, Therapeutika, Diagnostika und Screening-Agenzien bei inflammatorischen und Immunerkrankungen Analogues, agonists, antagonists, and variants of the oxidoreductase enzyme activity of macrophage migration inhibitory factor (MIF) as immunomodulators, therapeutic agents, diagnostic and screening agents in inflammatory and immune diseases
11/08/2007CA2803111A1 Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
11/08/2007CA2684314A1 Modulation of t helper cell-mediated immune responses
11/08/2007CA2650822A1 Antibodies binding to the extracellular domain of the receptor tyrosine kinase alk
11/08/2007CA2650730A1 Methods and compositions for antibody therapy
11/08/2007CA2650676A1 Feline cell capable of being cultured without animal-derived protein, and method for producing virus and method for producing vaccine using thereof
11/08/2007CA2650591A1 Methods for the treatment of flavivirus infection, molecules and uses thereof
11/08/2007CA2650459A1 Antibodies for the detection of bacillus anthracis and vaccine against b. anthracis infections
11/08/2007CA2650375A1 Genetic adjuvants for viral vaccines
11/08/2007CA2650270A1 High-titer retroviral packaging cells
11/08/2007CA2649057A1 Phl p 1 allergen derivative
11/08/2007CA2648882A1 Humanized c-kit antibody
11/08/2007CA2648086A1 Methods and compositions for inducing an immune response to hiv and models for testing
11/08/2007CA2648077A1 Parenteral low dose type 1 interferons for bladder cancer
11/08/2007CA2647985A1 High titer recombinant influenza viruses for vaccines
11/08/2007CA2647942A1 Combined mucosal and parenteral immunization against hiv
11/08/2007CA2647939A1 Methods and compositions for vaccination of poultry
11/08/2007CA2647544A1 Covalently-linked complexes of hiv tat and env proteins
11/08/2007CA2647542A1 Reagents and methods for cancer treatment and prevention
11/08/2007CA2647359A1 Tumor cell differentiation agents as chemical inhibitors and treatments for intracellular parasites
11/08/2007CA2647277A1 Method for using boc/cdo to modulate hedgehog signaling
11/08/2007CA2646406A1 Anti-igf-ir antibodies and uses thereof
11/08/2007CA2646048A1 Compositions and methods of use for antibodies of c-met
11/08/2007CA2638133A1 Anti-ephrinb2 antibodies and methods using same
11/08/2007CA2631961A1 Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r
11/07/2007EP1852505A1 Mutations in ion channels
11/07/2007EP1852432A1 Nitrogenous heterocyclic compound and medicinal use thereof
11/07/2007EP1852128A1 An anti HSP90 antibody
11/07/2007EP1852127A1 Use of a B-cell-depleting antibody for treatment of polyoma virus infections
11/07/2007EP1852126A2 Vaccine for modulating between T1 and T2 immune responses
11/07/2007EP1852125A2 Neisserial vaccine compositions and methods
11/07/2007EP1852123A2 Activation and inhibition of the immune system
11/07/2007EP1851338A2 Multi-component inhibitors of nucleic acid polymerases
11/07/2007EP1851320A1 Vaccines based on the use of mva
11/07/2007EP1851316A1 Means for obtaining avirulent leishmania promastigotes, promastigotes obtained, and the applications thereof
11/07/2007EP1851315A1 Human antibodies against rabies and uses thereof
11/07/2007EP1851308A1 Cd4+ cd25+ t-cells activated to a specific antigen
11/07/2007EP1851249A2 Cd20 antibody variants and uses thereof
11/07/2007EP1851246A1 Site-specific immunization in order to establish antibodies with specificity for the e7 oncoprotein of high-risk hpvs
11/07/2007EP1851244A1 An anti-cd137 antibody as an agent in the treatement of cancer and glycosylation variants thereof
11/07/2007EP1851238A2 Influenza nucleic acids, polypeptides, and uses thereof
11/07/2007EP1850874A2 Extending time to disease progression or survival in cancer patients using a her dimerization inhibitor
11/07/2007EP1850873A2 Antibodies to tgfbeta
11/07/2007EP1850872A2 A method of using an anti-cd137 antibody as an agent for radioimmunotherapy or radioimmunodetection
11/07/2007EP1850871A2 Adjuvant composition comprising aluminium phosphate and 3d-mpl
11/07/2007EP1850870A1 Composition for adjuvant containing poly-gamma-glutamic acid
11/07/2007EP1850869A2 Nucleic acid constructs
11/07/2007EP1850868A2 Oral vaccines for fish
11/07/2007EP1850867A1 Method of treating staphylococcus aureus infection
11/07/2007EP1850866A2 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
11/07/2007EP1850865A2 Antilymphocyte antibody induction by combination of an s1p receptor agonist/modulator and of immunosuppressive drugs
11/07/2007EP1850864A1 New detoxification method
11/07/2007EP1850860A2 Prostate stem cell antigen vaccines and uses thereof
11/07/2007EP1850850A2 Compositions and methods for targeted delivery of immune response modifiers
11/07/2007EP1850832A1 Adjuvanting material
11/07/2007EP1651684B1 Etherified carbamate functional copolymers of isobutylene type monomers, and their use in curable compositions
11/07/2007EP1534311B1 Method for identifying modulators of ion channels
11/07/2007EP1374901B9 Graft rejection suppressors
11/07/2007EP1087941B9 Thiolesters and uses thereof
11/07/2007EP1003379B1 Novel phytase
11/07/2007EP0939648B1 Rotavirus vaccine formulations
11/07/2007CN101068933A Fiber-modified adenoviral vectors for enhanced transduction of tumor cells
11/07/2007CN101068836A Anti-glypican 3 antibody having modified sugar chain
11/07/2007CN101068569A Anti-cancer virus desensitization method
11/07/2007CN101068568A Anti-malaria prime/boost vaccines
11/07/2007CN101068567A Chimeric phage-derived particles, methods for their production and use
11/07/2007CN101068566A Streptococcus agalactiae vaccine
11/07/2007CN101067001A Human glycosyl-phosphatidyl inositol-CD80 fusion protein
11/07/2007CN101066997A Human antibodies that bind human IL-12 and methods for producing
11/07/2007CN101066995A Ox C3d3 molecule as molecular adjuvant and its prepn process
11/07/2007CN101066991A Antigenic determinant polypeptide of human tumor-testis antigen HCA587 and its application
11/07/2007CN101066450A Antibody-containing solution preparation
11/07/2007CN101066449A Recombinant fowl pos virus vaccine rFPV 1218AIH5/N1 and its construction process and use
11/07/2007CN101066448A Recombinant fowl pos virus vaccine rFPV 1218AIH5/H9 and its construction process and use
11/07/2007CN101066447A Group b streptococcus proteins, and their use
11/07/2007CN100347191C 新mhcⅱ相关肽 New mhcⅱ related peptide
11/07/2007CN100347189C High-level composing production for anthrax protection antigen
11/07/2007CN100346830C Medicinal composition for treating B cell lymph tumour
11/07/2007CN100346829C Adjuvant compsn comprising immunostimulatory oligonucleotide and tocol
11/07/2007CN100346828C Immunogenic compositions
11/07/2007CN100346827C Viral chimeras comprised of CAEV and HIV-1 genetic elements
11/07/2007CN100346826C Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS
11/07/2007CN100346825C Method of vaccination of newly hatched poultry
11/07/2007CN100346824C 自体t－细胞疫苗材料和方法 Autologous t- vaccine MATERIALS AND METHODS Cell
11/07/2007CN100346822C Leukocyte inactivation module
11/07/2007CN100346789C Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury
11/06/2007USRE39914 Isolating sample selected from the group consisting of a body fluid, feces, a sample of tissue and a sample of an organ from the person, obtaining an antibody specific to an adenovirus type 36p; assaying the sample using the antibody to test for the presence of the adenovirus type 36p
11/06/2007US7291722 Polypeptide from haemophilus influenza
11/06/2007US7291721 Anti-IL-6 antibodies, compositions, methods and uses
11/06/2007US7291710 Detection of spectrin and spectrin proteolytic cleavage products in assessing nerve cell damage
1 ... 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 ... 1823